Background/Aim. Malnutrition, a common
problem in liver cirrhosis and HCC, may readily deteriorate the
clinical functions with resultant poor prognosis. Beside the hyper
catabolic state frequently encountered in chronic liver disease
and HCC, anorexia and reduced food intake also worsen the
malnutrition. The recently discovered peptide hormone ghrelin acts
as a counterpart of leptin in regulation of food intake and fat
utilization. The aim of the present study was to investigate the
ghrelin and leptin levels in cirrhosis and HCC due to hepatitis B
and D viruses, and the association of ghrelin and leptin with
TNF-α, IL-6 and the severity of the disease.
Materials and methods. We measured serum ghrelin, leptin,
TNF-α, and IL-6 levels using specific immunoassay in 45
patients (23 cirrhosis, 22 HCC) with HBV and/or HDV and in 25
control subjects. Results. In comparison to controls,
serum ghrelin, TNF-α, and IL-6 levels were significantly
higher in cirrhosis and HCC (P < .05), whereas serum leptin levels
were found decreased (P < .05). There was a positive correlation
between ghrelin and TNF-α, and a negative correlation
between leptin and TNF-α (P < .05). Conclusion.
In cirrhosis and HCC due to HBV or HDV, serum ghrelin levels were
increased with a corresponding decrease in serum leptin
concentrations, acting as a physiological counterpart of ghrelin.
The increasing of ghrelin is more prominent in Child C cirrhosis
and the level was correlated with TNF-α. The presence of
nutritional and metabolic abnormalities, including malnutrition,
in cirrhosis and HCC may, at least partly, elucidate high ghrelin
and low leptin levels.
EGCG reduces the development of experimental non-alcoholic steatohepatitis induced by a high fat diet. It seems to exercise this effect through its effect on lipid metabolism and antioxidant characteristics.
We investigated the preventive effect of lycopene on nonalcoholic steatohepatitis-induced by high-fat diet in rats. Forty male Sprague-Dawley rats were divided into 4 groups. They were fed standard diet, high-fat diet (HFD), high-fat diet plus lycopene at a dose of 2 mg/kg body weight and the high-fat diet lycopene at a dose of 4 mg/kg BW for a period of 6 weeks. Inflammation, steatosis, α-smooth muscle actin (α-SMA), and cytochrome P450 2E1 (CYP 2E1) expression increased significantly in the rats fed HFD and decreased in the rats administered by lycopene. Significantly elevated levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor (TNF α), and serum and liver malondialdehyde (MDA) were observed in rats fed the high-fat diet as compared to the control rats (P < .01). Supplementation with lycopene lowered serum MDA and tumor necrosis factor (TNF-α) levels and elevated liver GSH level (P < .001). Insulin resistance was higher in the rats fed HFD than in rats supplemented with lycopene. The data indicate that supplementation with lycopene can reduce high-fat diet-induced oxidative stress to the cells.
Aim. In the present study, we investigated the protective effect of genistein in experimental acute liver damage induced by CCl4. Method. Forty rats were equally allocated to 5 groups. The first group was designated as the control group (group 1). The second group was injected with intraperitoneal CCl4 for 3 days (group 2). The third group was injected with subcutaneous 1 mg/kg genistein for 4 days starting one day before CCl4 injection. The fourth group was injected with intraperitoneal CCl4 for 7 days. The fifth group was injected with subcutaneous 1 mg/kg genistein for 8 days starting one day before CCl4 injection. Plasma and liver tissue malondialdehyde (MDA) and liver glutathione levels, as well as AST and ALT levels were studied. A histopathological examination was conducted. Results. Liver tissue MDA levels were found significantly lower in group 3, in comparison to group 2 (P < .05). Liver tissue MDA level in group 5 was significantly lower than that in group 4
(P < .001). Liver tissue glutathione levels were higher in group 5 and 3, relative to groups 4 and 2, respectively (P > .05 for each). Inflammation and focal necrosis decreased in group 3, in comparison to group 2 (P < .001 for each). Inflammation and focal necrosis in group 5 was lower than that in group 4
(P < .001). Actin expression decreased significantly in group 5, relative to group 4
(P < .05). Conclusion. Genistein has anti-inflammatory and antinecrotic effects on experimental liver damage caused by CCl4. Genistein reduces liver damage by preventing lipid peroxidation and strengthening antioxidant systems.
Genistein, a strong antioxidant agent, significantly decreased the plasma TNF-alpha level and remarkably prevented the emergence of NASH by improving the biochemical and histopathological abnormalities via attenuating oxidative stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.